Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Raltegravir is a recently, Food and Drug Administration-approved, small-molecule drug that inhibits retroviral integrase, thereby preventing HIV DNA from inserting itself into the human genome. We report here that the activity profile of raltegravir on the replication of murine leukemia virus is similar to that for HIV, and that the drug specifically affects autoimmune disease in mice, in which endogenous retroelements are suspected to play a role. While NZW and BALB/c mice, which do not succumb to autoimmune disease, are not affected by raltegravir, lupus-prone (NZBxNZW) F 1 mice die of glomerulonephritis more than a month earlier than untreated mice. Raltegravir-treated NZB mice, which share the H-2 haplotype with BALB/c mice, but which are predisposed to autoimmune hemolytic anemia, develop auto-antibodies to their red blood cells >3 months earlier than untreated mice of the same strain. Because nonautoimmune mice are not affected by raltegravir, we consider off-target effects unlikely and attribute the exacerbation of autoimmunity to the inhibition of retroviral integrase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280 · cited 8×
“The processed ends would identify the DNA as generated by reverse transcriptase and distinguish it from external plasmid DNA, which is not degraded by Trex1 (1).”
BackgroundInfluentialInhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131 · cited 4×
“This ‘‘processing’’ reaction takes place in the cytoplasm when reverse transcriptase has finished the late double-stranded cDNA product of retrovirus, and it is required for integration into genomic DNA (27) (see Fig.”
BackgroundMethodInfluentialLee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2091 · Cited by 730 · cited 1×
“That these elements may contribute to autoimmune disease is indicated by the fact that human patients with a deficiency in Trex1, an enzyme that degrades retroelement cDNA (1), may suffer from chilblain lupus (2, 3), systemic lupus erythematosus (4), or Aicardi-Goutières syndrome (2, 3, 5).”
BackgroundRice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410 · cited 1×
“That these elements may contribute to autoimmune disease is indicated by the fact that human patients with a deficiency in Trex1, an enzyme that degrades retroelement cDNA (1), may suffer from chilblain lupus (2, 3), systemic lupus erythematosus (4), or Aicardi-Goutières syndrome (2, 3, 5).”
BackgroundMurray, J. M., Emery, S., Kelleher, A. D., Law, M., Chen, J., Hazuda, D. J., Nguyen, B.-Y. T., Teppler, H., & Cooper, D. A. (2007) · AIDS · doi:10.1097/qad.0b013e3282f12377 · Cited by 187 · cited 1×
“Of all classes of drugs, the integrase inhibitor raltegravir (21, 22) causes the fastest decline of HIV viremia in humans, even with monotherapy (48) and its rapid accumulation of HIV mutants.”
Background
Cited by
An autoimmune disease prevented by anti-retroviral drugs
Beck-Engeser, G. B., Eilat, D., & Wabl, M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-91 · Cited by 117
“Along this line, raltegravir, a drug that inhibits retroviral integrase and thus increases the concentration of cDNA in the cell, also exacerbates autoimmune disease [10].”
BackgroundSelf-citationEndogenous retroviral pathogenesis in lupus
Perl, A., Fernandez, D., Telarico, T., & Phillips, P. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833c6297 · Cited by 75
Role of endogenous retroviruses in murine SLE
Baudino, L., Yoshinobu, K., Morito, N., Santiago-Raber, M.-L., & Izui, S. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.07.012 · Cited by 54
Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
Koh, Y., Matreyek, K. A., & Engelman, A. (2011) · Journal of Virology · doi:10.1128/jvi.02541-10 · Cited by 37
Metadata
- Authors
- Beck-Engeser, G. B., Eilat, D., Harrer, T., Jäck, H.-M., & Wabl, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-12-08
- Volume
- 106
- Issue
- 49
- Pages
- 20865-20870
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2047998244
- Cited by
- 40
- References
- 5
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir. https://app.cochat.ai/papers/10.1073/pnas.0908074106
- The paper
- Beck-Engeser, G. B., Eilat, D., Harrer, T., Jäck, H.-M., & Wabl, M. (2009). Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0908074106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.